FR2185414A1 - - Google Patents

Info

Publication number
FR2185414A1
FR2185414A1 FR7319087A FR7319087A FR2185414A1 FR 2185414 A1 FR2185414 A1 FR 2185414A1 FR 7319087 A FR7319087 A FR 7319087A FR 7319087 A FR7319087 A FR 7319087A FR 2185414 A1 FR2185414 A1 FR 2185414A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7319087A
Other versions
FR2185414B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2185414A1 publication Critical patent/FR2185414A1/fr
Application granted granted Critical
Publication of FR2185414B1 publication Critical patent/FR2185414B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
FR7319087A 1972-05-25 1973-05-25 Expired FR2185414B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722226703 DE2226703A1 (de) 1972-05-25 1972-05-25 Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2185414A1 true FR2185414A1 (fr) 1974-01-04
FR2185414B1 FR2185414B1 (fr) 1976-08-13

Family

ID=5846530

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7319087A Expired FR2185414B1 (fr) 1972-05-25 1973-05-25

Country Status (12)

Country Link
JP (1) JPS4941367A (fr)
AT (1) AT323155B (fr)
AU (1) AU5607873A (fr)
BE (1) BE800066A (fr)
CA (1) CA1005062A (fr)
CH (1) CH582144A5 (fr)
CS (1) CS179416B2 (fr)
DD (1) DD106170A5 (fr)
DE (1) DE2226703A1 (fr)
FR (1) FR2185414B1 (fr)
GB (1) GB1436893A (fr)
NL (1) NL7307313A (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235903A (en) * 1979-08-06 1980-11-25 American Home Products Corporation 1-Hydroxyalkanamine tetrahydrocarbazoles and cyclopent[b]indoles, compositions and method of use
US6545034B1 (en) 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US7129262B2 (en) 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7361680B2 (en) 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7151100B1 (en) 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
DE10164564B4 (de) * 2001-12-14 2007-05-16 Zentaris Gmbh Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)
AU2003295336A1 (en) 2002-09-19 2004-04-08 Dennis A. Carson Use of etodoclac to treat hyperplasia
US20060074124A1 (en) * 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
WO2005026112A2 (fr) * 2003-09-12 2005-03-24 Elixir Pharmaceuticals, Inc. Procedes de traitement de troubles
JP2007507524A (ja) 2003-10-02 2007-03-29 セフアロン・インコーポレーテツド インドール誘導体
EP2326621B1 (fr) * 2008-07-23 2016-06-08 Arena Pharmaceuticals, Inc. Dérivés de l acide 1,2,3,4-tétrahydrocyclopenta[b]indol-3-yle acétique substitué utilisés dans le traitement des maladies auto-immunes et inflammatoires
RS54970B1 (sr) 2008-08-27 2016-11-30 Arena Pharm Inc Supstituisani triciklični derivati kiselina kao s1p1 receptor agonisti korisni pri lečenju autoimunih i upalnih poremećaja
EP3378854B1 (fr) 2010-01-27 2022-12-21 Arena Pharmaceuticals, Inc. Procédés de préparation d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclopenta[b]indol-3-yl) acétique et de ses sels
CA2789480A1 (fr) 2010-03-03 2011-09-09 Arena Pharmaceuticals, Inc. Procedes de synthese de modulateurs des recepteurs s1p1 et leurs formes cristallines
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
SI3310760T1 (sl) 2015-06-22 2023-02-28 Arena Pharmaceuticals, Inc. Kristalinična L-argininska sol (R)-2-(7-(4-ciklopentil-3-(trifluorometil)benziloksi)-1,2,3,4- tetrahidrociklo-penta(b)indol-3-il)ocetne kisline za uporabo pri motnjah, povezanih z receptorjem S1P1
MA47503A (fr) 2017-02-16 2021-04-21 Arena Pharm Inc Composés et méthodes pour le traitement de maladies inflammatoires chroniques de l'intestin avec manifestations extra-intestinales
KR20190116416A (ko) 2017-02-16 2019-10-14 아레나 파마슈티칼스, 인크. 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법
US11555015B2 (en) 2018-09-06 2023-01-17 Arena Pharmaceuticals, Inc. Compounds useful in the treatment of autoimmune and inflammatory disorders
CN114634442B (zh) * 2022-04-02 2023-10-13 内蒙古民族大学 一种四氢咔唑酮化合物的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100677A1 (fr) * 1970-05-25 1972-03-24 Hoffmann La Roche
FR2103403A1 (fr) * 1970-08-20 1972-04-14 Organon Nv

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100677A1 (fr) * 1970-05-25 1972-03-24 Hoffmann La Roche
FR2103403A1 (fr) * 1970-08-20 1972-04-14 Organon Nv

Also Published As

Publication number Publication date
CH582144A5 (fr) 1976-11-30
NL7307313A (fr) 1973-11-27
AT323155B (de) 1975-06-25
CS179416B2 (en) 1977-10-31
FR2185414B1 (fr) 1976-08-13
AU5607873A (en) 1974-11-28
GB1436893A (en) 1976-05-26
DD106170A5 (fr) 1974-06-05
CA1005062A (en) 1977-02-08
JPS4941367A (fr) 1974-04-18
BE800066A (fr) 1973-11-26
DE2226703A1 (de) 1973-12-13

Similar Documents

Publication Publication Date Title
FR2208967A1 (fr)
FR2185414B1 (fr)
FR2208222A1 (fr)
JPS49132688A (fr)
JPS4918671U (fr)
JPS5243236Y2 (fr)
JPS4916535U (fr)
JPS4963499U (fr)
JPS5341902Y2 (fr)
JPS4955084A (fr)
JPS49100110U (fr)
JPS4933722U (fr)
CH583192A5 (fr)
CH575901A5 (fr)
SE7416281L (fr)
AU480303A (fr)
CH573038A5 (fr)
BG17915A1 (fr)
BG17918A1 (fr)
DD106060A5 (fr)
CH584275A5 (fr)
CH573673A5 (fr)
CH582640A5 (fr)
CH578749A5 (fr)
CH571500A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse